EAM
AMPH icon

Eagle Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Eagle Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,042
Closed -$2.23M – 563
2023
Q4 		$2.23M Sell
36,042
-1,659
-4% -$87.1K 0.01% 443
2023
Q3 		$1.73M Sell
37,701
-31,888
-46% -$1.74M 0.01% 447
2023
Q2 		$4M Sell
69,589
-237,181
-77% -$10.5M 0.02% 380
2023
Q1 		$11.5M Buy
306,770
+5,897
+2% +$193K 0.07% 230
2022
Q4 		$8.48M Sell
300,873
-9,382
-3% -$272K 0.05% 261
2022
Q3 		$8.72M Buy
310,255
+82,796
+36% +$2.7M 0.06% 254
2022
Q2 		$7.91M Buy
227,459
+50,120
+28% +$1.79M 0.05% 281
2022
Q1 		$6.37M Sell
177,339
-74,277
-30% -$2.11M 0.03% 353
2021
Q4 		$5.82M Sell
251,616
-33,002
-12% -$675K 0.03% 387
2021
Q3 		$5.41M Sell
284,618
-19,856
-7% -$389K 0.02% 391
2021
Q2 		$6.14M Sell
304,474
-5,985
-2% -$113K 0.03% 391
2021
Q1 		$5.62M Sell
310,459
-1,964
-0.6% -$36.5K 0.02% 399
2020
Q4 		$6.28M Buy
312,423
+28,179
+10% +$548K 0.04% 361
2020
Q3 		$5.29M Sell
284,244
-16,974
-6% -$342K 0.03% 358
2020
Q2 		$6.66M Sell
301,218
-16,770
-5% -$307K 0.04% 336
2020
Q1 		$4.72M Buy
317,988
+33,752
+12% +$587K 0.03% 367
2019
Q4 		$5.48M Buy
+284,236
New +$5.45M 0.03% 396

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Eagle Asset Management's AMPH Position: Q1 2024 in Review

Eagle Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 36,042 shares — an estimated $2.23M sold.

Eagle Asset Management first reported a position in AMPH in Q4 2019 and held it in 17 quarters. The position peaked at $11.5M in Q1 2023. 270 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

  • Eagle Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 36,042 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $2.23M.
  • Eagle Asset Management first reported a position in Amphastar Pharmaceuticals in Q4 2019 and held it in 17 quarters.
  • Eagle Asset Management's Amphastar Pharmaceuticals position peaked at $11.5M in Q1 2023.
  • 270 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.